Brand Story
30 May 2023, 09:59 GMT+10
The global central venous catheters (CVCs) market is expected to grow at a 5.3% CAGR from US$ 1.3 billion in 2022 to US$ 1.6 billion by 2026. The global market for medical devices used to insert catheters into large veins for various medical purposes is referred to as the Central Venous Catheters (CVCs) Market. These catheters, which are typically made of silicone or polyurethane, can be placed in the internal jugular, subclavian, or femoral veins. CVCs are commonly used in critical care settings for patients who require long-term intravenous medications, nutrition, or blood products. Patients who require hemodialysis, apheresis, or plasmapheresis may also benefit from them. In addition, CVCs are used to monitor central venous pressure (CVP).
The global CVCs market is expected to expand significantly over the next few years, owing to rising chronic disease prevalence, rising demand for advanced medical devices, and rising healthcare expenditure.
Download Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=7645
Key Takeaways from Central Venous Catheters Market Study
Key Segments in Central Venous Catheters Industry Research
Region-Wise Analysis
The central venous catheters (CVCs) market is a global market that can be segmented into various regions including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the largest share of the market due to the high adoption of advanced technologies, increasing prevalence of chronic diseases, and rising geriatric population. Europe is also a significant market due to the presence of established healthcare infrastructure and high healthcare expenditure. The Asia-Pacific region is expected to grow rapidly due to increasing healthcare expenditure, rising awareness about healthcare, and growing geriatric population. The market in Latin America and Middle East & Africa is expected to grow moderately due to improving healthcare infrastructure and rising investments in the healthcare sector
Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=7645
Winning Strategy
To lower bloodstream infections, market companies are focusing on launching antimicrobial-coated catheters and stepping up their R&D efforts. To minimise risks and ensure patient safety, central venous catheter manufacturers are putting more focus on investments in product quality and design.
In the upcoming years, industry players believe that regulatory authority suggestions regarding the categorization of central venous catheters, which are now being sought for, will significantly fuel market expansion.
For instance,
Key players in the Central Venous Catheters Market
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationDAYTON, Ohio: Under an agreement announced this week, Joby Aviation will produce state-of-the-art electric vertical takeoff and landing (eVTOL) aircraft ...
NEW YORK, New York - U.S. stocks and bonds caught on to a global trend Thursday as sellers took charge ...
CHICAGO, Illinois: The Chicago Symphony Orchestra (CSO) and the Chicago Federation of Musicians announced over the weekend that they agreed ...
ANKARA, Turkey: During a meeting, Michael Evans, President of the Alibaba Group, told Turkish President Tayyip Erdogan that the Chinese ...
NEW YORK: This week, the Wall Street Journal (WSJ) reported that U.S. electric vehicle (EV) maker Tesla and Saudi Arabia ...
NEW YORK, New York - Interest rates could stay higher for longer, but there is the possibility of rate cuts ...
DAYTON, Ohio: Under an agreement announced this week, Joby Aviation will produce state-of-the-art electric vertical takeoff and landing (eVTOL) aircraft ...
NEW ORLEANS, Louisiana: As Midwest farmers prepare to harvest crops and send tons of grain downriver to the Gulf of ...
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...
(Photo credit: Darren Yamashita-USA TODAY Sports) Two teams with an eye on "second place" continue their four-game series on Friday ...
(Photo credit: Kamil Krzaczynski-USA TODAY Sports) The Minnesota Twins will open their final homestand of the regular season with a ...
(Photo credit: David Richard-USA TODAY Sports) The Cleveland Guardians will turn to a familiar face in a bid to stave ...